Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-07
1999-11-30
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 9321, 435325, 4353723, 514 9, A61K 3170, A61K 3813, A61K 4800, C12N 510
Patent
active
059943130
ABSTRACT:
We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.
REFERENCES:
patent: 5171671 (1992-12-01), Evans et al.
patent: 5589362 (1996-12-01), Bujard et al.
Durand et al., "Characterization of Antigen Receptor Response Elements Within the Interleukin-2 Enhancer"; Mol. Cell Biol. 8(2):1715-1724 (1988).
Letourneur and Klausner, Activation of T Cells by a Tyrosine Kinase Activation Domain in the Cytoplasmic Tail of CD3 .epsilon.; Science 255:79-82 (1992).
Flanagan et al., "Nuclear Association of a T-Cell Transcription Factor Blocked by FK-506 and Cyclosporin A"; Nature 352:803-807 (1991).
Fisher et al., "On the Remarkable Propensity for Carbon-Carbon Bond Cleavage Reactions in the C.sub.8 -C.sub.10 Region of FK-506"; J. Org. Chem. 56:2900-2907 (1991).
VanRheenen et al., "An Improved Catalytic OsO.sub.4 Oxidation of Olefins to Cis-1,2-Glycols Using Tertiary Amine Oxides as the Oxidant"; Tetrahedron Letters 23:1973-1976 (1976).
Fields, S. and Song, O., "A novel genetic system to detect protein--protein interactions"; Nature 340:245-246 (1989).
Ghosh et al., "N,N'-Disuccinimidyl Carbonate: A Useful Reagent for Alkoxycarbonylation of Amines"; Tetrahedron Letters 33:2781-2784 (1992).
Zelle et al., "A Systematic Degradation of Zincophorin: A Stereoselective Synthesis of the C.sub.17 -C.sub.25 Fragment"; J. Org. Chem. 51:5032-5036 (1986).
Krishnamurthy, "Lithium Tris[(3-ethyl-3-pentyl)oxy]aluminum Hydride. A New Remarkably Chemoselective Reagent for the Reduction of Aldehydes in the Presence of Ketones"; J. Org. Chem. 46:4628-4629 (1981).
Nussbaumer et al., C9-Imino and C10-Amino Derivatives of Ascomycin (21-Ethyl-FK506); Tetrahedron Letters 33:3845-3846 (1992).
Evans et al., "Rhodium(I)- and Iridium(I)-Catalyzed Hydroboration Reactions: Scope and Synthetic Applications"; J. Am. Chem. Soc. 114:6671-6679 (1992).
Evans et al., "Mechanistic Study of the Rhodium(I)-Catalyzed Hydroboration Reaction"; J. Am. Chem. Soc. 114:6679-6685 (1992).
Traber et al., "Cyclosporins--New Analogues by Precursor Directed Biosynthesis"; J. Antibiotics 42:591-597 (1989).
Patchett et al., "Analogs of Cyclosporin A Modified at the D-ALA.sup.8 Position"; J. Antibiotics 45:94-102 (1992).
Donald et al., "C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Peptidyl-Prolyl Cis-Trans Isomerization"; Tetrahedron Letters 31:1375-1378 (1991).
Byrn et al., "Biological Properties of a CD4 Immunoadhesin"; Nature 344:667-670 (1990).
Lanier et al., "Co-association of CD3.zeta. with a Receptor (CD16) for IgG Fc on Human Natural Killer Cells"; Nature 342:803-805 (1989).
Mattila et al., "The Actions of Cyclosporin A and FK506 Suggest a Novel Step in the Activation of T Lymphocytes"; EMBO J. 9(13):4425-4433 (1990).
Verweij et al., "Cell Type Specificity and Activation Requirements for NFAT-1 (Nuclear Factor of Activated T-Cells) Transcriptional Activity Determined by a New Method Using Transgenic Mice to Assay Transcriptional Activity of an Individual Nuclear Factor"; J. Biol. Chem. 265(26):15788-15795 (1990).
Clark et al., "The B Cell Antigen Receptor Complex: Association of Ig-.alpha. and Ig-.beta. with Distinct Cytoplasmic Effectors"; Science 258:123-126 (1992).
Shaw et al., "Identification of a Putative Regulator of Early T Cell Activation Genes"; Science 241:202-205 (1988).
Weissman et al., "Molecular Cloning and Chromosomal Localization of the Human T-Cell Receptor .zeta. Chain: Distinction from the Molecular CD3 Complex"; Proc. Natl. Acad. Sci. USA 85:9709-9713 (1988).
Emmel et al., "Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T-Cell Activation"; Science 246:1617-1620 (1989).
Eberle and Nuninger, "Synthesis of the Main Metabolite (OL-17) of Cyclosporin A"; J. Org. Chem. 57:2689-2691 (1992).
Irving and Weiss, "The Cytoplasmic Domain of the T Cell Receptor .zeta. Chain is Sufficient to Couple to Receptor-Associated Signal Transduction Pathways"; Cell 64:891-901 (1991).
Kinet, "Antibody-Cell Interactions: Fc Receptors"; Cell 57:351-354 (1989).
Orloff et al., "Family of Disulphide-Linked Dimers Containing the .zeta. and .eta. Chains of the T-Cell Receptor and the .gamma. Chain of Fc Receptors"; Nature 347:189-191 (1990).
Itoh and Nagata, "A Novel Protein Domain Required for Apoptosis", JBC 268:10932-10937 (1993).
Ptashne et al., "Activators and Targets", Nature 346:329-331 (1990).
Schreiber, "Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands", Science 251:283-287 (1991).
Palmiter et al., "Transgenic Mice", Cell 41:343-345 (1985).
Itoh et al., "Effect of bc1-2 on Fas Antigen-Mediated Cell Death", Journal of Immunology 151:621-627 (1993).
Spencer et al (1993) Science 262:1019-1024.
Watson et al. (1994) The G-Protein Linked Receptor Facts Book, Academic Press Limited, San Diego, pp. X-Xi, 3-6.
Travis (1993) Science 262:989.
Metzger et al. (1995) Proc. Natl. Acad. Sci. USA 92:6991-6995.
Logie et al. (1995) Proc. Natl. Acad. Sci. USA 92:5940-5944.
Kappel et al. (1992) Current Opinion in Biotechnology 3:548-553.
Spencer et al. (1994) J. Cellular Biochemistry. Supp. 18A:252.
Selvakumaran M., et al, "Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis", (1993) Blood 81(9):2257-62.
Weiss, A., "T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases." (1993) Cell, 73(2):209-12.
Rudert F., et al, "Apoptosis in L929 cells expressing a CD40/Fas chimeric receptor: dissociation of stimulatory from inhibitory death signalling functions.", (1994) Biochem Biophys Res Commun, 204(3):1102-10.
Belshaw Peter
Crabtree Gerald R.
Schreiber Stuart L.
Spencer David M.
Wandless Thomas J.
Berstein David L.
Board of Trustees of the Leland S. Stanford, Jr. Univ.
Elliott George C.
Hausdorff Sharon F.
President and Fellows of Harvard College
LandOfFree
Regulated apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulated apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672673